Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT
- PMID: 1673293
- PMCID: PMC1683037
Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT
Abstract
The inactivation of two alleles at a locus on the short arm of chromosome 11 (band 11p13) has been suggested to be critical steps in the development of Wilms tumor (WT), a childhood kidney tumor. Two similar candidate WT cDNA clones (WT33 and LK15) have recently been identified on the basis of both their expression in fetal kidney and their location within the smallest region of overlap of somatic 11p13 deletions in some tumors. These homozygous deletions, however, are large and potentially affect more than one gene. Using a cDNA probe to the candidate gene, we have analyzed DNA from both normal and tumor tissue from WT patients, in an effort to detect rearrangements at this locus. We report here a patient with bilateral WT who is heterozygous for a small (less than 11 kb) germinal deletion within this candidate gene. DNA from both tumors is homozygous for this intragenic deletion allele, which, by RNA-PRC sequence analysis, is predicted to encode a protein truncated by 180 amino acids. These data support the identification of this locus as an 11p13 WT gene (WT1) and provide direct molecular data supporting the two-hit mutational model for WT.
Similar articles
-
Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.Int J Cancer. 1995 Nov 15;63(4):516-22. doi: 10.1002/ijc.2910630410. Int J Cancer. 1995. PMID: 7591260
-
Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.Br J Cancer. 1993 Jun;67(6):1259-61. doi: 10.1038/bjc.1993.235. Br J Cancer. 1993. PMID: 8390282 Free PMC article.
-
Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.Oncogene. 1992 Jun;7(6):1215-21. Oncogene. 1992. PMID: 1350671
-
Wilms tumor genes.Biochim Biophys Acta. 1993 Dec 23;1155(3):295-306. doi: 10.1016/0304-419x(93)90011-z. Biochim Biophys Acta. 1993. PMID: 8268188 Review.
-
Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.Genes Chromosomes Cancer. 1992 Nov;5(4):326-34. doi: 10.1002/gcc.2870050408. Genes Chromosomes Cancer. 1992. PMID: 1283321 Review.
Cited by
-
Implications of the Wilms' Tumor Suppressor Wt1 in Cardiomyocyte Differentiation.Int J Mol Sci. 2021 Apr 21;22(9):4346. doi: 10.3390/ijms22094346. Int J Mol Sci. 2021. PMID: 33919406 Free PMC article.
-
Candidate genes and potential targets for therapeutics in Wilms' tumour.Clin Transl Oncol. 2010 Sep;12(9):597-605. doi: 10.1007/s12094-010-0564-y. Clin Transl Oncol. 2010. PMID: 20851800 Review.
-
The Denys-Drash syndrome.J Med Genet. 1994 Jun;31(6):471-7. doi: 10.1136/jmg.31.6.471. J Med Genet. 1994. PMID: 8071974 Free PMC article. Review. No abstract available.
-
Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.Jpn J Cancer Res. 1993 Jun;84(6):616-24. doi: 10.1111/j.1349-7006.1993.tb02021.x. Jpn J Cancer Res. 1993. PMID: 8393432 Free PMC article.
-
Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.Genes Dev. 1998 Apr 15;12(8):1108-20. doi: 10.1101/gad.12.8.1108. Genes Dev. 1998. PMID: 9553041 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources